Qian Fang Pharmaceutical's workshop and quality inspection building were designed according to GMP requirements. From June 1 to February10.50 billion tablets, the annual output of granules/KLOC-0.50 billion tons, capsules/KLOC-0.50 billion tablets, 50 million bottles of syrup and 200,000 bottles of wine and tincture for external use was improved. In Guilin, where the natural conditions are superior, the company has planted nearly100,000 mu of Sophora japonica according to the requirements of national GMP, with an annual output of 20,000 tons of high-quality Sophora japonica and 6000 tons of rutin (more than 95%). Having equipment and precision instruments that meet the production requirements and quality inspection requirements, so that the production and quality control meet GMP requirements. The company passed GMP certification on May 25th, 2004.
Qian Fang Pharmaceutical Co., Ltd. has equipped and condensed all kinds of professionals with modern enterprise management mechanism and the enterprise spirit of "down-to-earth, do more and talk less", which has a good development foundation. Company leaders all have bachelor degree or above, all have more than 10 years of practical experience in drug production management, and can lead enterprises to organize production and management according to the requirements of good production practices; The person in charge of each management department has a college degree or above; The personnel of the quality and drug production management departments all have technical secondary school education or above; Quality inspection operators have relevant professional knowledge and take up their posts after passing professional technical training; All employees of the company have passed the training and assessment of the Drug Administration Law, the Regulations for the Implementation of the Drug Administration Law and the good manufacturing practice. All production operators have junior high school education or above, and they have been trained in professional knowledge and post SOP, and they will take up their posts after passing the examination. Management departments and operators at all levels have the ability to ensure that enterprises carry out drug production, quality management and sales in accordance with good manufacturing practice. The company has 667 employees, including 8 managers1person, 2 senior titles, 26 intermediate titles, 4 junior titles1person, 92 production workers1person and 352 sales staff.
Qian Fang Pharmaceutical Co., Ltd. adheres to high standards and a high starting point, strives to be in line with international standards, actively introduces modern enterprise management systems, establishes an organizational system with clear responsibilities, and improves enterprise rules and regulations. In terms of product quality control, the whole production process is monitored in strict accordance with GMP standards. In terms of production management, we have strengthened the staff's quality awareness, strengthened on-site management, ensured product quality, adhered to the enterprise development tenet of quality first, and paid full attention to everyone's health, which has contributed to the prosperity of the pharmaceutical market and the revitalization of the local economy.
Legal Representative: Fang Shizhuang
Date of establishment: June 2002-10
Registered capital: 90 million yuan.
Venue: Guangxi Zhuang Autonomous Region
Unified social credit code: 9145030020040445j
Business status: surviving (in business, in business, on record)
Industry: manufacturing industry
Company type: other joint stock limited companies (unlisted)
English name: Guangxi Changfang Pharmaceutical Co., Ltd.
Staff size: 100-500 people.
Address: No.38, Chengnan Road, Quanzhou Town, quanzhou county, Guilin, Guangxi.
Business scope: production and sales: tablets, oral liquid, wine, syrup, granules, tincture (for external use) (including pretreatment and extraction of traditional Chinese medicine) raw materials and hard capsules; Production and sales: antibacterial (bacteriostatic) preparation (liquid dosage form, the product must pass the health and safety evaluation for the first time); Acquisition of local Chinese herbal medicines; Agricultural and sideline products processing; Production and sales: tea-containing products, tea substitute [tea-containing products (instant tea)]; Chinese herbal medicine cultivation; Production and sales of oral solid medicinal high-density polyethylene bottles and oral liquid medicinal high-density polyethylene bottles; Import and export business permitted by the state; Research and sales of plant extracts (except for administrative licensing approval items); Production and operation of food and food additives (with valid license).